Objective: The aims of this study was to evaluate the feasibility and safety of a robotic single-site staging (RSSS) operation for early-stage endometrial cancer and to standardize of technique.
Methods: A total of 50 Patients with a preoperative diag...
Objective: The aims of this study was to evaluate the feasibility and safety of a robotic single-site staging (RSSS) operation for early-stage endometrial cancer and to standardize of technique.
Methods: A total of 50 Patients with a preoperative diagnosis of early endometrial cancer (International Federation of Gynecology and Obstetrics stages IA to IB) from endometrial curettage and preoperative imaging studies were selected and underwent the RSSS operation from March 2014 to December 2018. All surgical procedures, including hysterectomy, salpingo-oophorectomy, pelvic and/or para-aortic node dissection, and cytology aspiration, were performed by robotic single-site instruments (da Vinci Si® surgical system; Intuitive Surgical, Sunnyvale, CA, USA).
Results: The median patient age and body mass index were 52.6 years and 26.2 kg/m2. The median docking time, console time, and total operative time were 7 minutes, 75 minutes, and 120 minutes, respectively. The median retrieval of both pelvic lymph nodes was 11. There were no conversions to laparoscopy or laparotomy.
Conclusion: In this study, operative times were reasonable, and the surgical procedure was well-tolerated by the patients. The RSSS operation is a feasible and safe surgical treatment option in patients with early-stage endometrial cancer.